• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立一种新型细胞系,用于生产具有复制能力的无复制缺陷腺病毒。

Establishment of a novel cell line for producing replication-competent adenovirus-free adenoviruses.

机构信息

GENEUINTECH Co., Ltd., Inje University, 197 Injero, Gimhae, Gyeongnam, 50834, Republic of Korea.

Laboratory of Microbiology and Immunology, College of Pharmacy, Inje University, 197 Injero, Gimhae, Gyeongnam, 50834, Republic of Korea.

出版信息

BMC Biotechnol. 2024 Sep 27;24(1):67. doi: 10.1186/s12896-024-00894-x.

DOI:10.1186/s12896-024-00894-x
PMID:39334326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11429178/
Abstract

Adenoviruses are commonly utilized as viral vectors for gene therapy, genetic vaccines, and recombinant protein expression. To generate replication-defective adenoviruses, E1-complementing cell lines such as HEK293A are utilized; however, limitations remain. Repeated passage of E1-deleted virus in HEK293A cells increases the occurrence of replication-competent adenoviruses (RCAs). In the present study, we developed a novel cell line originating from human primary cells. L132 cells were transduced two times with E1-encoded retrovirus and three times with E1A-encoded retrovirus. Finally, we selected the most productive L132 cell line for generation of RCA-free adenovirus, GT541. GT541 can serve as an alternative cell line to HEK293A and other adenovirus-producing cells.

摘要

腺病毒通常被用作基因治疗、基因疫苗和重组蛋白表达的病毒载体。为了生成复制缺陷型腺病毒,需要使用 E1 互补细胞系,如 HEK293A;然而,仍存在一些限制。在 HEK293A 细胞中反复传代 E1 缺失病毒会增加复制型腺病毒(RCAs)的发生。在本研究中,我们开发了一种源自人原代细胞的新型细胞系。L132 细胞两次转导 E1 编码的逆转录病毒,三次转导 E1A 编码的逆转录病毒。最后,我们选择了最具生产效率的 L132 细胞系来生成无 RCA 的腺病毒 GT541。GT541 可作为 HEK293A 和其他腺病毒生产细胞的替代细胞系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a0/11429178/6074c7f1efab/12896_2024_894_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a0/11429178/e759dd9dbe09/12896_2024_894_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a0/11429178/950b2c247c1f/12896_2024_894_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a0/11429178/2bc4ad0e7297/12896_2024_894_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a0/11429178/d5e6f58fe510/12896_2024_894_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a0/11429178/b2559f6c80b6/12896_2024_894_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a0/11429178/e057076476ad/12896_2024_894_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a0/11429178/6074c7f1efab/12896_2024_894_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a0/11429178/e759dd9dbe09/12896_2024_894_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a0/11429178/950b2c247c1f/12896_2024_894_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a0/11429178/2bc4ad0e7297/12896_2024_894_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a0/11429178/d5e6f58fe510/12896_2024_894_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a0/11429178/b2559f6c80b6/12896_2024_894_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a0/11429178/e057076476ad/12896_2024_894_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a0/11429178/6074c7f1efab/12896_2024_894_Fig7_HTML.jpg

相似文献

1
Establishment of a novel cell line for producing replication-competent adenovirus-free adenoviruses.建立一种新型细胞系,用于生产具有复制能力的无复制缺陷腺病毒。
BMC Biotechnol. 2024 Sep 27;24(1):67. doi: 10.1186/s12896-024-00894-x.
2
TRIM56 enhances adenoviral E1A steady state to improve oncolytic adenovirus therapy efficacy.TRIM56增强腺病毒E1A的稳态以提高溶瘤腺病毒治疗效果。
J Virol. 2025 Jul 22;99(7):e0004125. doi: 10.1128/jvi.00041-25. Epub 2025 Jun 3.
3
Cellular transcription factor TFII-I represses adenovirus gene expression.细胞转录因子TFII-I抑制腺病毒基因表达。
J Virol. 2025 Jun 17;99(6):e0061825. doi: 10.1128/jvi.00618-25. Epub 2025 May 12.
4
Tat-dependent conditionally replicating adenoviruses expressing diphtheria toxin A for specifically killing HIV-1-infected cells.依赖 Tat 的条件复制型腺病毒表达白喉毒素 A 特异性杀伤 HIV-1 感染细胞。
Mol Ther. 2024 Jul 3;32(7):2316-2327. doi: 10.1016/j.ymthe.2024.05.015. Epub 2024 May 11.
5
Product Enhanced Reverse Transcriptase for assessing replication competent virus in vectors retroviral vectors pseudotyped with GALV and VSV-G envelopes.产品增强型逆转录酶,用于评估带有 GALV 和 VSV-G 包膜的逆转录病毒载体中复制型病毒。
J Virol Methods. 2024 Sep;329:114988. doi: 10.1016/j.jviromet.2024.114988. Epub 2024 Jun 20.
6
Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.源自人肺癌A549细胞的新型互补细胞系支持E1缺失腺病毒载体的生长。
Gene Ther. 1996 Jan;3(1):75-84.
7
Stable expression of shRNA for the control of recombinant adenovirus replication.稳定表达短发夹 RNA 以控制重组腺病毒复制。
Braz J Med Biol Res. 2023 Jul 21;56:e12682. doi: 10.1590/1414-431X2023e12682. eCollection 2023.
8
Overexpression of tumor suppressor TSLC1 by a survivin-regulated oncolytic adenovirus significantly inhibits hepatocellular carcinoma growth.肿瘤抑制因子 TSLC1 的过表达被生存素调控的溶瘤腺病毒显著抑制肝癌的生长。
J Cancer Res Clin Oncol. 2012 Apr;138(4):657-70. doi: 10.1007/s00432-011-1138-2. Epub 2012 Jan 12.
9
Protease-deleted adenovirus as an alternative for replication-competent adenovirus vector.缺失蛋白酶的腺病毒作为复制型腺病毒载体的替代物。
Virology. 2023 Sep;586:67-75. doi: 10.1016/j.virol.2023.07.009. Epub 2023 Jul 19.
10
New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.新型辅助细胞和匹配的E1区缺失腺病毒载体可防止产生具有复制能力的腺病毒。
Hum Gene Ther. 1998 Sep 1;9(13):1909-17. doi: 10.1089/hum.1998.9.13-1909.

本文引用的文献

1
Adenoviral Gene Therapy Vectors in Clinical Use-Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on Clinical Safety.临床应用的腺病毒基因治疗载体 - 以复制型腺病毒形成及其对临床安全性的影响为例的基本方面。
Int J Mol Sci. 2023 Nov 20;24(22):16519. doi: 10.3390/ijms242216519.
2
The human adenovirus E1B-55K oncoprotein coordinates cell transformation through regulation of DNA-bound host transcription factors.人腺病毒 E1B-55K 癌蛋白通过调节与 DNA 结合的宿主转录因子来协调细胞转化。
Proc Natl Acad Sci U S A. 2023 Oct 31;120(44):e2310770120. doi: 10.1073/pnas.2310770120. Epub 2023 Oct 26.
3
Comparison among plaque assay, tissue culture infectious dose (TCID) and real-time RT-PCR for SARS-CoV-2 variants quantification.
用于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株定量的蚀斑试验、组织培养感染剂量(TCID)和实时逆转录聚合酶链反应(RT-PCR)之间的比较。
Iran J Microbiol. 2022 Jun;14(3):291-299. doi: 10.18502/ijm.v14i3.9758.
4
Antigen Delivery Systems: Past, Present, and Future.抗原递送系统:过去、现在与未来
Biomol Ther (Seoul). 2023 Jul 1;31(4):370-387. doi: 10.4062/biomolther.2023.006. Epub 2023 Apr 19.
5
The Adenovirus Vector Platform: Novel Insights into Rational Vector Design and Lessons Learned from the COVID-19 Vaccine.腺病毒载体平台:对合理载体设计的新见解和从 COVID-19 疫苗中吸取的经验教训。
Viruses. 2023 Jan 11;15(1):204. doi: 10.3390/v15010204.
6
A qPCR-Based Method for Quantification of RCA Contaminants in Oncolytic Adenovirus Products.一种基于定量聚合酶链反应的方法用于定量溶瘤腺病毒产品中的RCA污染物。
Front Mol Biosci. 2022 May 23;9:883249. doi: 10.3389/fmolb.2022.883249. eCollection 2022.
7
HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors.HEK293细胞系作为生产重组蛋白和病毒载体的平台。
Front Bioeng Biotechnol. 2021 Dec 13;9:796991. doi: 10.3389/fbioe.2021.796991. eCollection 2021.
8
On the Calculation of TCID for Quantitation of Virus Infectivity.用于病毒感染性定量的半数组织培养感染剂量(TCID)的计算
Virol Sin. 2021 Feb;36(1):141-144. doi: 10.1007/s12250-020-00230-5. Epub 2020 May 26.
9
Establishing Suspension Cell Cultures for Improved Manufacturing of Oncolytic Adenovirus.建立悬浮细胞培养体系以提高溶瘤腺病毒的生产。
Biotechnol J. 2020 Apr;15(4):e1900411. doi: 10.1002/biot.201900411. Epub 2020 Jan 27.
10
The biology of the adenovirus E1B 55K protein.腺病毒 E1B 55K 蛋白的生物学特性。
FEBS Lett. 2019 Dec;593(24):3504-3517. doi: 10.1002/1873-3468.13694. Epub 2019 Dec 8.